RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

PIER 88 INVESTMENT PARTNERS LLC's Holding History (CIK: 0001697366)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 97,140 Value ($000) $397 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 118,560 Value ($000) $579 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 74,510 Value ($000) $377 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 94,790 Value ($000) $501 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 161,730 Value ($000) $1,093 Avg Close $6.72 Range $5.60 - $9.55

Q3 2024

Shares 133,910 Value ($000) $882 Avg Close $7.17 Range $5.88 - $8.73

Q2 2024

Shares 24,700 Value ($000) $185 Avg Close $8.72 Range $6.75 - $10.66

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	97,140	$397	$4.95	$3.81 - $7.18
Q3 2025	118,560	$579	$5.25	$4.45 - $7.15
Q2 2025	74,510	$377	$4.91	$3.79 - $6.11
Q1 2025	94,790	$501	$7.29	$5.19 - $12.36
Q4 2024	161,730	$1,093	$6.72	$5.60 - $9.55
Q3 2024	133,910	$882	$7.17	$5.88 - $8.73
Q2 2024	24,700	$185	$8.72	$6.75 - $10.66